The Journal of Urology
Volume 182, Issue 6, Supplement , Pages S27-S31, December 2009

Obesity and Benign Prostatic Hyperplasia: Clinical Connections, Emerging Etiological Paradigms and Future Directions

  • J. Kellogg Parsons

      Affiliations

    • Division of Urologic Oncology, Moores Cancer Center, University of California, San Diego and Section of Surgery, San Diego Veterans Affairs Medical Center, La Jolla, California
    • Corresponding Author InformationCorrespondence: Division of Urology, University of California-San Diego, 200 West Arbor Dr., No. 8897, San Diego, California 92103-8897 (telephone: 619-543-2630; FAX: 619-543-6573)
    • Financial interest and/or other relationship with American Medical Systems.
  • ,
  • Aruna V. Sarma

      Affiliations

    • Department of Epidemiology, Ann Arbor, Michigan
    • Department of Urology, Ann Arbor, Michigan
  • ,
  • Kevin McVary

      Affiliations

    • Department of Urology, Northwestern University, Chicago, Illinois
    • Financial interest and/or other relationship with GlaxoSmithKline, Pfizer, Lilly/ICOS, Sanofi-Aventis, Allergan and National Institute of Diabetes and Digestive and Kidney Diseases.
  • ,
  • John T. Wei

      Affiliations

    • Department of Urology, Ann Arbor, Michigan
    • Financial interest and/or other relationship with Sanofi, American Medical Systems, Envisioneering, Gen-Probe and Beckman.

published online 20 October 2009.

Purpose

Benign prostatic hyperplasia is a highly prevalent disease in older men with substantial adverse effects on public health. Classic etiological paradigms for benign prostatic hyperplasia focus on nonmodifiable risk factors. However, obesity also potentially promotes benign prostatic hyperplasia.

Materials and Methods

We performed a structured, comprehensive literature review to identify studies of obesity, benign prostatic hyperplasia, lower urinary tract symptoms and physical activity.

Results

A preponderance of published evidence suggests strong positive associations of obesity with benign prostatic hyperplasia and lower urinary tract symptoms. This evidence encompasses most established metrics of adiposity, including body mass index, waist circumference and waist-to-hip ratio, and falls under 3 general categories, including prostate volume, clinical benign prostatic hyperplasia and lower urinary tract symptoms. 1) Prior studies consistently showed that increased adiposity is positively associated with radiographically determined prostate volume and enlargement, suggesting that obesity promotes prostate growth. 2) Most studies revealed that obesity increases the risk of clinical benign prostatic hyperplasia by several measures, including the initiation of benign prostatic hyperplasia medical treatment, noncancer prostate surgery, physician diagnosed benign prostatic hyperplasia, histological diagnosis and urinary flow rate. 3) Prior studies demonstrated that obesity increases the risk of lower urinary tract symptoms, as measured by a validated questionnaire. Also, most studies showed that physical activity significantly decreases the risk of benign prostatic hyperplasia.

Conclusions

Obesity markedly increases the risk of benign prostatic hyperplasia. Since physical activity decreases the risk of benign prostatic hyperplasia, these observations support the development of novel prevention strategies and treatment targeted toward adiposity, weight loss and lifestyle.

Key Words: prostate, prostatic hyperplasia, urination disorders, obesity, metabolic syndrome X

Abbreviations and Acronyms: BLSA, Baltimore Longitudinal Study of Aging, BMI, body mass index, BPH, benign prostatic hyperplasia, HPS, Health Professionals Follow-up Study, I-PSS, International Prostate Symptom Score, LUTS, lower urinary tract symptoms, NHANES, National Health and Nutrition Examination Survey, PCPT, Prostate Cancer Prevention Trial

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-5347(09)01834-5

doi:10.1016/j.juro.2009.07.086

The Journal of Urology
Volume 182, Issue 6, Supplement , Pages S27-S31, December 2009